Evidence map›Paper›PMID 14769943›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Danielle M Friedrichsen, Janet L Stanford, Sarah D Isaacs, Marta Janer, Bao-Li Chang, Kerry Deutsch, Elizabeth Gillanders, Suzanne Kolb, Katherine E Wiley, Michael D Badzioch and 8 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13.Journal of the American Society of Nephrology : JASN · 2009
    Article
  6. Article
  7. Article
  8. Prostate cancer susceptibility loci: finding the genes.Advances in experimental medicine and biology · 2008
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Danielle M FriedrichsenDivisions of Clinical Research and Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Janet L Stanford
Sarah D Isaacs
Marta Janer
Bao-Li Chang
Kerry Deutsch
Elizabeth Gillanders
Suzanne Kolb
Katherine E Wiley
Michael D Badzioch
S Lilly Zheng
Patrick C Walsh
Gail P Jarvik
Leroy Hood
Jeffrey M Trent
William B Isaacs
Elaine A Ostrander
Jianfeng Xu
University of Washington · US

Funding

TRANSGENIC MODELS FOR PROSTATE CANCER AND AUTOIMMUNITYP50CA058236 · NCI · JOHNS HOPKINS UNIVERSITY · PI TROCK, BRUCE J · 1992 to 2020
$43.9M
Prostate Cancer Susceptibility: The ICPCG StudyU01CA089600 · NCI · MAYO CLINIC ROCHESTER · PI THIBODEAU, STEPHEN NORMAN · 2002 to 2016
$27.3M
Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
GENETIC EPIDEMIOLOGY OF PROSTATE CANCERR01CA080122 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STANFORD, JANET L · 1999 to 2008
$3.8M
GENETICS OF PROSTATE CANCER SUSCEPTIBILITYR01CA078836 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, PETER S · 1999 to 2005
$3.3M
Genetics of Cancer Susceptibility--Multisystem ApproachK05CA090754 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OSTRANDER, ELAINE A · 2001 to 2004
$373k
NCI NIH HHS K05 CA090754NCI NIH HHS K05CA90754NCI NIH HHS P50 CA058236NCI NIH HHS R01 CA078836NCI NIH HHS R01 CA080122NCI NIH HHS R01 CA089600NCI NIH HHS R01 CA58236NCI NIH HHS R01 CA78836NCI NIH HHS R01 CA80122NCI NIH HHS T32 CA080416NCI NIH HHS U01 CA089600
6 · The paper itself

Abstract

Results from over a dozen prostate cancer susceptibility genome-wide scans, encompassing some 1,500 hereditary prostate cancer families, indicate that prostate cancer is an extremely heterogeneous disease with multiple loci contributing to overall susceptibility. In an attempt to reduce locus heterogeneity, we performed a genomewide linkage scan for prostate cancer susceptibility genes with 36 Jewish families, which represent a stratification of hereditary prostate cancer families with potentially increased locus homogeneity. The 36 Jewish families represent a combined dataset of 17 Jewish families from the Fred Hutchinson Cancer Research Center-based Prostate Cancer Genetic Research Study dataset and 19 Ashkenazi Jewish families collected at Johns Hopkins University. All available family members, including 94 affected men, were genotyped at markers distributed across the genome with an average interval of <10 centimorgans. Nonparametric multipoint linkage analyses were the primary approach, although parametric analyses were performed as well. Our strongest signal was a significant linkage peak at 7q11-21, with a nonparametric linkage (NPL) score of 3.01 (P = 0.0013). Simulations indicated that this corresponds to a genomewide empirical P = 0.006. All other regions had NPL P values >/=0.02. After genotyping additional markers within the 7q11-21 peak, the NPL score increased to 3.35 (P = 0.0004) at D7S634 with an allele-sharing logarithm of odds of 3.12 (P = 0.00007). These studies highlight the utility of analyzing defined sets of families with a common origin for reducing locus heterogeneity problems associated with studying complex traits.

Indexed as

AdultAgedAllelesChromosome MappingChromosomes, Human, Pair 7Genetic Predisposition to DiseaseGenotypeHumansJewsLod ScoreMaleMiddle AgedProstatic Neoplasms

Identifiers

PMID14769943
PMCPMC357031
OpenAlexW2098117001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.